Icon
+91 94997 68112
Login Register

Lexette - (0.05% Aerosol foam)

Halobetasol Propionate Mayne Pharma
0.05% Aerosol foam
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
Less Than 5
 None
Halobetasol Propionate Topical Foam is indicated for the topical treatment of plaque psoriasis in patients 18 years of age and older
Yes
***** ****** **** ******* ** ****** ’*** ** *** **, ****. ** **** *, **** ******* ******* *** **** ** *******. *** **** ******* *** *********** ** ******* ** **** ****. *** *** ******* ** *** **, ****. ** ** ********* ** *******'* ********* ******** ****** **** **** ***'* **** ** ****** ******* ****** *** ******.
Lexette Patent 1 Patent 2
******* ******* *** ********* (***** ******)
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
******* ***\ ********* *** **, **** ******* ******** ***** *** **, ****
  1. *** **, **** : ***** ****** **** ******* ** ****** '***.
  2. *** *, **** : ******* ******* *** **** ** *******. *** **** ******* *** *********** ** ******* ** **** ****.
  3. *** **, **** : ***** ****** ******* **** ******* / ******* **** ******* *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.